Angiotensin-converting enzyme inhibitors in patients with bronchial responsiveness and asthma.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 1555463.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Twenty-one subjects with known bronchial hyperreactivity were prospectively randomized in double-blind fashion to receive one of two angiotensin-converting enzyme inhibitors (ACE-I), enalapril or spirapril, for three weeks. Spirometry and methacholine provocation were performed prior to, during, and following ACE-I usage. Three of 21 subjects developed a nonproductive cough. However, only one subject wheezed slightly. Spirometry and bronchial reactivity (PD20) were unchanged throughout the study.
Medical subject headings
- Angiotensin-Converting Enzyme Inhibitors
- Asthma
- Bronchial Hyperreactivity